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Attenuation of age-related sarcopenia by creatine supplementation has been equivocal. In this study, plantaris muscles of young
(Y; 5m) and aging (A; 24m) Fisher 344 rats underwent four weeks of either control (C), creatine supplementation (Cr), surgical
overload (O), or overload plus creatine (OCr). Creatine alone had no eﬀect onmuscle fiber cross-sectional area (CSA) or heat shock
protein (HSP70) and increased myonuclear domain (MND) only in young rats. Overload increased CSA and HSP70 content in I
and IIA fibers, regardless of age, and MND in IIA fibers of YO rats. CSA and MND increased in all fast fibers of YOCr, and CSA
increased in I and IIA fibers of AOCr. OCR did not alter HSP70, regardless of age. MND did not change in aging rats, regardless of
treatment. These data indicate creatine alone had no significant eﬀect. Creatine with overload produced no additional hypertrophy
relative to overload alone and attenuated overload-induced HSP70 expression.
1. Introduction
Aging is associated with reductions in skeletal muscle mass
and strength (sarcopenia), which may lead to impaired mo-
bility in older individuals. Despite a litany of research on sar-
copenia, the underlying mechanisms remain to be eluci-
dated. Comprehensive reviews of the potential mechanisms
behind sarcopenia are available (e.g., Ryall et al. 2008 [1]).
In brief, declines in muscle-specific stem cells (satellite cells);
increases inmyostatin, a negative regulator ofmuscle growth;
changes in circulating hormone levels; impairment of neuro-
muscular function; increased myonuclear apoptosis have all
been proposed as mechanisms underlying sarcopenia.
Creatine (C4H9N3O2) supplementation is a popular die-
tary supplement with recreational and professional athletes.
It has been shown to increase exercise performance [2, 3]
and strength [4]. Creatine is a naturally occurring molecule
in skeletal muscle and can be synthesized or obtained in
the diet. Creatine and phosphocreatine (PCr) are involved
in coupling anaerobic metabolism with ATP demand [5].
Increased intramuscular levels of PCr may permit increased
temporal buﬀering of ATP during high-intensity muscle con-
traction, and increased creatine levels may allow increased
PCr resynthesis [6]. In so doing, creatine supplementation
may indirectly increase muscle mass and strength by allowing
training at higher workloads [7]. However, the mechanisms
behind the enhancement of performance and increases in
muscle strength by creatine supplementation have not been
fully elucidated.
The use of a dietary supplement, such as creatine, to
counteract sarcopenia is not unprecedented. Other nutri-
tional interventions have produced positive results against
sarcopenia. High protein diets may be beneficial for stimu-
lating protein synthesis in the muscles of aging individuals
[8]. The use of creatine in elderly populations is of interest
because of its potential to increase energy production, fat-
free mass, and muscle mass [9]. Combined, these eﬀects
would increase the ability of the elderly to perform everyday
tasks such as rising from a seated position and walking. How-
ever, older individuals appear to respond diﬀerently than
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young individuals to creatine supplementation [10]. Short
durations of creatine supplementation alone in elders have
shown mixed results. Creatine supplementation for five days
in aging population had no eﬀect on isometric strength
[11, 12]. Similarly, five days of creatine supplementation had
no eﬀect on pedaling performance in cycling-trained elderly
subjects [13]. Conversely, 5 days of creatine supplementation
increased anaerobic power and work capacity of sedentary
elderly subjects [13]. Short-term creatine supplementation
has also produced increases in strength and fat-free mass of
elderly men [14] and women [15].
Longer-term creatine supplementation combined with
resistance training in the elderly has also demonstrated var-
ied responses. The combined treatments resulted in anything
from no extra benefit after 8 weeks of strength training and
supplementation [16], to small increases in muscle strength
after 12 weeks [17], to moderate increases in strength and
creatine levels after 14 weeks [18], beyond resistance training
alone. It has recently been shown that low-dose creatine sup-
plementation combined with protein supplementation and
resistance training for 10 weeks increases lean tissue mass but
not leg press strength [19]. Furthermore, there was a greater
response in creatine combined with protein supplementation
than creatine alone or placebo. Conversely, neither creatine
supplementation, protein supplementation, or a combina-
tion of protein and creatine was shown to provide further
benefit beyond 16 weeks of isotonic resistance training alone
in elderly subjects [20].
In light of these controversial results, an animal model of
hypertrophy (surgical ablation/compensatory hypertrophy)
was chosen to compare the eﬀects of creatine supplementa-
tion on hypertrophy in young and aging rats. Surgical ab-
lation is an animal model involving surgical removal of a
muscle, thereby overloading its synergistic muscles and caus-
ing them to hypertrophy in compensation [21–23]. The
authors are aware of one other study that used this model
to study creatine supplementation. Dangott et al. [24]
showed no further hypertrophy inmuscle fibers with creatine
supplementation above compensatory hypertrophy alone.
However, that study did not separate muscle into individual
fiber types. Our study was designed to investigate whether
creatine supplementation alone, surgical ablation alone, or
a combination of creatine supplementation and surgical
ablation would lead to hypertrophy in individual fiber types
of the plantaris muscle. Furthermore, surgical ablation has
been associated with increased expression of heat shock
protein 70 (HSP70), which has been linked to myoprotection
[25, 26] and anabolism [27, 28]. Therefore, the study ex-
amined whether these experimental treatments would alter
HSP70 levels and whether hypertrophic and/or HSP70
responses would diﬀer in young compared to older animals
after these interventions. It was hypothesized that creatine
supplementation would primarily increase CSA in fast fibers
(IIA, IIB/D) and that this would be attenuated in aging
muscle. We further hypothesized that HSP70 levels would
be elevated in treatment groups undergoing surgical ablation
but that creatine alone would not significantly alter HSP70
levels, regardless of age.
2. Materials and Methods
2.1. Animals. Young (5 months at muscle excision, N = 27)
and aging (24 months at muscle excision, N = 35) adult
male Fisher 344 rats from National Institute on Aging rodent
colony (Harlan Labs, Indianapolis, IN) were used. Animals
were divided into eight groups: (1) young control (YC, N =
6); (2) young supplemented with creatine (YCr, N = 7); (3)
young overloaded (YO, N = 7); (4) young overloaded and
supplemented with creatine (YOCr, N = 7); (5) aging con-
trol (AC, N = 8); (6) aging supplemented with creatine
(ACr, N = 9); (7) aging overloaded (AO, N = 9); (8) aging
overloaded and supplemented with creatine (AOCr, N = 9).
All rats were housed at the Ohio University Animal Facility.
They were housed individually and provided with free access
to rat chow and water. Temperature was maintained at
22◦C ± 2◦C, and conditions consisted of a 12-hour: 12-
hour dark-light cycle. The experiments were approved by the
IACUC of Ohio University.
2.2. Surgical Procedure. Animals were allowed 10 days of
recovery from shipping and to become accustomed to their
surroundings prior to experimentation. At that point, four
experimental groups (YO, YOCr, AO, and AOCr) underwent
surgical ablation surgery to induce overload by compen-
satory hypertrophy. Rats were anesthetized intraperitoneally
by injection of either Veterinary Pentothol (∼0.07mg/kg
body weight) or a combination of Xylazine and Ketamine
(0.01 g/kg body weight Xylazine; 0.01 g/kg body weight
Ketamine). When there was no reflex response, an incision
(∼2.5 cm) was made through the skin of the posterior com-
partment of the leg to expose the underlying muscle. The
distal third of the gastrocnemius was removed bilaterally.
Bilateral surgery ensured the animal would not favor either
leg. The plantaris and the soleusmuscles were left intact. Care
was taken to ensure blood supply and innervation to remain-
ingmuscles were not compromised. The incision was sutured
with 4.0 black braided silk and the stitches were approxi-
mately 0.3 cm apart, ensuring the incision was completely
closed. After overnight recovery from the anesthetic, the
animals were returned to their cages.
2.3. Creatine Supplementation. After returning to their cages,
dietary creatine supplementation began for those in the
creatine groups (YCr; YOCr; ACr; AOCr). Rats were given
creatine monohydrate, 4.45 g/L (Sigma-Aldrich, St. Louis,
MO) with a 5% dextrose solution (Sigma-Aldrich, St. Louis,
MO) in the drinking water, ad libitum. Consumption of
creatine solution was measured daily. The groups not receiv-
ing creatine were given 5% dextrose in the drinking water.
The dextrose solution was chosen because creatine uptake is
increased when combined with a carbohydrate solution [29].
Fluid levels for all rats were measured and replaced daily.
Supplementation was continued for 4 weeks.
2.4. Muscle Extraction. Four weeks after the surgical ablation
and/or beginning of creatine supplementation, the animals
were killed, and the plantaris muscles were prepared for
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analysis. Samples were mounted for cross-sectioning in a
mixture of tragacanth gum and optimal cutting temperature
(OCT) cutting medium (Sakura Finetek Co., Torrence, CA)
and frozen in methyl butane (Fisher Chemicals, Fair Lawn,
NJ), cooled with liquid nitrogen. Samples were stored at
−80◦C until they were sectioned. Animals were subsequent-
ly euthanized by an anesthetic overdose, followed by heart
removal. Samples were cryosectioned at −20◦C to thick-
nesses of 8 µm for ATPase analysis and 6 µm for immuno-
histochemistry. Sections were placed onto cover slips coated
with poly-L-lysine and stored at −40◦C until the completion
of histochemical analysis.
2.5. Immunohistochemistry. Serial sections were immunos-
tained using primary antibodies against dystrophin (Sigma-
Aldrich, St. Louis, MO) and laminin (Santa Cruz Biotech-
nology, Santa Cruz, CA); heat shock protein 70 (N27F3-
4; Santa Cruz Biotechnology, Santa Cruz, CA); or myosin
heavy chains (A4.591 and N2.261; Developmental Studies
Hybridoma Bank, Iowa City, IA). The serial section stained
for dystrophin and laminin were blocked with blocking
serum, incubated with the primary antidystrophin antibody
(4◦C) overnight, washed with washing buﬀer, incubated in
biotinylated secondary antibody (Vector, Burlingame, CA),
washed, and labeled with the avidin-biotin complex (ABC)
reagent conjugated with peroxidase. The sections were then
incubated with antilaminin antibody (22◦C) for 60 minutes
and the same series of reactions repeated. The sections
were then incubated in Nickel-enhanced diaminobenzidine
(DAB; Pierce Chemical, Rockford, IL), counterstained with
Delafield’s hematoxylin and dehydrated in a graded alcohol
series, before clearing and mounting. All other serial sec-
tions were incubated in primary antibody for one hour at
37◦C, followed by the biotinylated secondary antibody, ABC
reagent, dehydration and mounting as described above.
2.6. Fiber Typing. Sections were stained formATPase activity,
using previously described techniques [30]. In brief, serial
sections were preincubated in a solution made to pH 4.15
or pH 4.45. These pH preincubations allowed Type I, Type
IIA, and Type IIB/D fibers to be characterized. Myosin
immunohistochemistry was performed on a subset of muscle
samples to validate the mATPase-based fiber type delin-
eation.
2.7. Cross-Sectional Area andMyonuclei. Cross-sectional area
(CSA) was measured for each muscle fiber on a computer
using a video captured microscope image of the cells stained
with dystrophin and laminin and NIH Image software.
Cross-sectional area was calculated for at least 300 fibers
(from 3 random microscope frames ∼0.56mm2), or all the
fibers in the sample.
The myonuclei were counted at 1000Xmagnification and
were identified due to their location inside the sarcolemma
and the basal lamina. The total number per fiber type and
total number per 100 fibers (%) were counted. Adjacent
sections prepared for myofibrillar ATPase were matched with
these fibers to characterize the fiber type and its properties.
2.8. Myonuclear Domain. Within a fiber type, the myonu-
clei/cytoplasm (N/C) ratio was determined to estimate
myonuclear domain (mean CSA/mean myonuclei) as previ-
ously published [31, 32]. Myonuclear domain was compared
between the 8 experimental conditions for a given fiber type.
2.9. Heat Shock Protein Quantification. Digital images of
samples stained for HSP70 were acquired using video-
capture microscopy (Figure 1). Light and diaphragm settings
were held constant for all image acquisition. To assess HSP70
content, pixel density was determined on at least 50 fibers, of
each major fiber type, per sample using NIH Image software.
All pixel density figures were normalized to an acellular
background on the coverslip of the sample.
2.10. Statistical Analysis. All statistical analyses were per-
formed using Systat 11. A two-way analysis of variance
(ANOVA) was used to compare the dependent variables
(creatine and overload) across ages and muscle fiber types.
Significance was set at P ≤ 0.05. Where significance was
found for main eﬀects, Fisher’s least significant diﬀerence
methodwas used for post hoc analysis. One-way ANOVAwas
used to compare creatine consumption, muscle mass, and
body mass across ages. Student’s-tests were used for animal
and muscle mass analyses. Significance was set at P ≤ 0.05.
Where significance was found for main eﬀects, Fisher’s least
significant diﬀerence method was used for post-hoc analysis.
3. Results
In the interest of full disclosure, some data from the con-
trol groups (both young and aging) have been previously
reported in Acta Physiologica [31]. However, no data from
either age category within the treatment groups (Cr, O, or
OCr) have been previously published, apart from conference
abstracts. Furthermore, this manuscript contains new data
from the control groups (e.g., HSP70).
3.1. Fluid Consumption and Creatine Intake. Fluid intake
is shown in Table 1. Older animals took in more creatine
solution than young (P < 0.05). For the duration of the study,
all animals had consistently more creatine intake than rec-
ommended for loading dose (0.3 g/kg body weight/day) and
maintenance dose (0.03 g/kg body weight/day) as advised in
the literature by Kreider and colleagues [33].
3.2. BodyMass andMuscle Mass. Bodymass was significantly
heavier in the aging rats, regardless of the treatment group
(Table 2). The within-subject diﬀerence in body mass be-
tween pre- and posttreatment showed both aging groups
that underwent surgical overload (AO and AOCr) lost mass.
Compared to the young overloaded animals (YO and YOCr),
these diﬀerences were significant (Table 2). In both the young
and aging animals, the plantaris muscle of OCr group was
heavier than control or creatine (young 30% heavier and
older 18% heavier; P < 0.05; Table 3). The ratio of plantaris
weight/body weight was also greater in the OCr group than
control or creatine in both young and aging animals. In each
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Figure 1: Immunohistochemical analysis of the plantaris. Micrographs representative of immunohistochemical assays for (a) HSP70, (b)
MHC I, and (c) MHC II (Bar = 100 µm).
Table 1: Fluid consumption and creatine intake for young and aging rats.
Young Aging
Fluid intake (mL/day) Creatine intake (g/kg body wt) Fluid intake (mL/day) Creatine intake (g/kg body wt)
Control 29± 6mL/day 36± 4mL/day
Creatine 30± 6mL/day 0.41± 0.07 g/kg 40± 4mL/day 0.47± 0.12 g/kg
Overload 28± 4mL/day 43± 10mL/day
Overload + Creatine 28± 2mL/day 0.42± 0.03 g/kg 50± 9mL/daya 0.58± 0.10 g/kgb
Data presented as Mean ± SD. aP < 0.05, greater than control group; bP < 0.05, old greater than young.
Table 2: Pre- and posttreatment weight of young and aging animals.
Young Aging
Weight (Pre; g)
Weight
(Post; g)
Change in
Weight
(Post-Pre; g)
Weight
(Pre; g)
Weight
(Post; g)
Change in
Weight
(Post-Pre; g)
Control 273.3± 27.8 296.0 ± 31.7 +22.8± 18.6 393.0± 25.8 416.8 ± 27.5d +23.8± 9.1
Creatine 285.4± 25.6 324.9± 25.4 +39.5± 14.4 373.8± 15.4 408.9± 19.7d +35.2± 8.3a
Overload 278.9± 12.7 302.6± 18.2 +23.8± 7.3 411.3± 21.5 388.8± 23. 2d −22.6± 12.2bc
Overload + creatine 272.8± 12.4 302.3± 11.6 +29.5± 7.6 394.2± 15.0 384.1± 18.0d −10.1± 9.5c
Data presented as Mean ± SD. aP < 0.001, greater than overload and OCr groups; bP < 0.05, less than OCr group; cP < 0.001, less body weight increase than
young; dP < 0.05, heavier than same treatment in young.
Table 3: Plantaris muscle weight and muscle weight/body weight ratio for young and aging animals.
Young Aging
Plantaris Wt (g) Ratio plantaris Plantaris Wt (g) Ratio plantaris
Wt/Body Wt Wt/Body Wt
Control 0.236± 0.030 0.080± 0.011 0.319± 0.040c 0.077± 0.009
Creatine 0.255± 0.030 0.080± 0.009 0.328± 0.037c 0.080± 0.009
Overload 0.276± 0.050 0.091± 0.015 0.358± 0.040c 0.092± 0.010b
Overload + creatine 0.308± 0.019a 0.102± 0.003b 0.375± 0.037ac 0.098± 0.008b
Data presented as Mean ± SD. aP < 0.05, heavier than control or creatine groups; bP < 0.05, higher ratio than control or creatine groups; cP < 0.05, heavier
than same treatment in young.
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Figure 2: Cross-sectional area for plantaris muscle in young and
aging animals for all treatment groups. Open bars are type I fibers,
grey bars are type IIA fibers, and closed bars are IID/B fibers. Data
are presented as mean ± SD. ∗Significantly diﬀerent than control
treatment, within age group (P < 0.05); #significantly diﬀerent than
creatine group, within age group (P < 0.05); $significantly diﬀerent
than same treatment in young rats (P < 0.05).
experimental group, older muscles were heavier than young
muscles in all groups (Table 3).
3.3. Young versus Aging Control Muscle. The plantaris muscle
was composed of predominantly fast fibers. Samples from
aging animals had a higher percentage type I fibers and
a lower percentage type IIA fibers than young animals
(Table 4). The percentage of type IIB/D fibers was similar
between young and aging animals. CSA data for type I, IIA,
and IIB/D fibers are presented in Figure 2. There were no
diﬀerences in CSA between young and older control animals
for any fiber type. CSA for IIB/D was greater than I or IIA for
all treatment groups (P < 0.05). Myonuclear domain size of
type IIB/D fibers was significantly larger than I or IIA fibers
within age groups of control animals (P < 0.05; Figure 3).
There was no diﬀerence in myonuclear domain between type
I and IIA fibers, within age groups. Type I and IIA fibers
of young control animals had significantly higher HSP70
content than in those same fiber types of aging control
animals (Figure 4). In the faster fibers of the plantaris, there
was no significant diﬀerence in HSP70 content between
young and aging animals of the control cohorts.
3.4. Creatine Supplementation. Creatine supplementation
had no significant eﬀect on fiber type composition. Fiber
CSA did not significantly diﬀer in animals receiving creatine
compared to control rats, regardless of fiber type or age.
However, trends toward significance were seen between YC
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Figure 3: Myonuclear domain size for plantaris muscle in young
and aging animals for all treatment groups. Open bars are type
I fibers, grey bars are type IIA fibers, and closed bars are IID/B
fibers. Data are presented as mean ± SD. ∗Significantly diﬀerent
than control treatment, within age group (P < 0.05); #significantly
diﬀerent than creatine group, within age group (P < 0.05);
$significantly diﬀerent than same treatment in young rats (P <
0.05). Units for myonuclear domain are myonuclei/um2.
and YCr treatment groups for CSA of type IIA (P =
0.057) and IIB/D (P = 0.087) fibers (2059.00 ± 115.28µm2
versus 1724.26 ± 380.61µm2, 28% diﬀerence and 3955.57 ±
264.98µm2 versus 3642.043 ± 648.06µm2, 17% diﬀerence,
resp.; Figure 2). In aging rats, creatine supplementation did
not significantly aﬀect fiber CSA for any fiber type. The
eﬀects of creatine supplementation on myonuclear domain
were both age and fiber type specific. In type I fibers of
young animals, themyonuclear domain size was not diﬀerent
between creatine supplementation and control animals. In
young animals, the myonuclear domain sizes of type IIA and
IIB/D fibers were significantly larger in creatine supplement-
ed rats than in control rats (IIA YCr = 1667.02± 274.34µm2
versus YC = 1463.63±400.77µm2 and IIB/D YCr = 2386.83±
368.47 µm2 versus YC = 1930.17 ± 405.09µm2; Figure 3).
Creatine supplementation had no eﬀect on myonuclear
domain size in aging animals compared to control animals,
regardless of fiber type. Myonuclear domain was significantly
diﬀerent between fiber types within age groups of creatine-
supplemented animals (P < 0.05), except there was no
diﬀerence between type I and IIA in YCr (P = 0.266).
Creatine supplementation alone had no significant eﬀects on
HSP70 content for any age or fiber type.
3.5. Muscle Overload. In the overload group, young animals
had significantly more type I fibers than control animals of
a similar age (Table 4). There was no diﬀerence between the
percentages of type I fibers in young and aging animals of
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Table 4: Percent fiber type of plantaris muscle for young and aging animals.
Young Aging
Type I % Type IIA % Type IIB/D % Type I % Type IIA % Type IIB/D %
Control 8± 2e 19± 3 74± 4 14± 3a 13± 4a 73± 2
Creatine 6± 4e 22± 4f 71± 6d 13± 7a,d 11± 3a,d 77± 7
Overload 19± 7c 20± 5 62± 5b,g 18± 7 18± 6 64± 9b,h
Overload + creatine 10± 4d 24± 7 66± 9b 17± 5a 16± 5a,g 67± 5g
Data presented as Mean ± SD. aaging significantly diﬀerent than young within treatment P < 0.05; bsignificantly diﬀerent than control within age group P <
0.05; csignificantly diﬀerent than control within age group P < 0.001; dsignificantly diﬀerent than overload within age group P < 0.05; esignificantly diﬀerent
than overload within age group P < 0.001; fyoung significantly diﬀerent than old within treatment P < 0.001; gsignificantly diﬀerent than creatine within age
group P < 0.05; hsignificantly diﬀerent than creatine within age group P < 0.001.
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Figure 4: Heat shock protein for plantaris muscle in young and
aging animals for all treatment groups. ∗indicates significantly
diﬀerent than control within age group (P < 0.05); #Indicates
significantly diﬀerent than surgical overload treatment within age
group (P < 0.05); $significantly diﬀerent than same treatment in
young rats (P < 0.05).
the overload treatment. This was diﬀerent from the other
groups in which the older animals had higher percentages
of type I fibers than the young animals (Table 4). Regardless
of age, the percentage of type IIB/D fibers was lower in the
overloaded group than in the control group.
Surgical overload significantly increased the CSA of
IIA fibers in the plantaris of young rats (35% diﬀerence,
2270.01±142.84µm2 versus 1724.26±380.61µm2, Figure 1).
The CSAs of type I and IIB/D fibers from overloaded rats
were larger than those fibers in control animals, but these
data failed to reach significance due to large variability in
the control animals (I 29%; 1841.68 ± 196.98µm2 versus
1635.95 ± 600.12µm2; IIB/D 12%; 3747.01 ± 263.40µm2
versus 3642.04± 648.06µm2; Figure 1). In the older animals,
overload induced fiber hypertrophy of the slow-twitch fiber
(21%; 1879.37 ± 212.47µm2 versus 1491.10 ± 299.40µm2)
and IIA (16%; 2112.83 ± 226.32µm2 versus 1768.15 ±
209.31µm2) fiber types compared to the control group
(Figure 2). However, CSA of type IIB/D fibers of aging
animals were not significantly diﬀerent between overloaded
and control groups (Figure 2).
Overload had very little eﬀect on myonuclear domain.
Only type IIA fibers of young, overloaded rats experienced
a significant increase in myonuclear domain (1858.96 ±
287.91µm2 versus 1463.63±400.77µm2; Figure 3). Overload
did not cause any other significant changes in myonuclear
domain size for any fiber type, irrespective of age (P >
0.05; Figure 3). Myonuclear domain size was smallest in
type I fibers; type IIA and IIB/D had significantly larger
domain sizes than type I in both young and older animals.
Myonuclear domain sizes were larger in type IIA fibers than
type I fibers of older animals compared to young animals
(P < 0.05). Myonuclear domain was significantly diﬀerent
between fiber types within age groups of overloaded muscle.
Surgical overload resulted in significantly elevatedHSP70
content, relative to control animals. This was true in type I
and IIA fibers of YO and AO cohorts. However, overload did
not aﬀect the HSP 70 content of type IID/B, regardless of age
group.
3.6. Overload and Creatine Supplementation. A combination
of overload and creatine supplementation did not have
the same influence on fiber type composition as overload
alone. In young rats, the YOCr treatment group had a
significantly lower percentage of type I fibers than the YO
treatment. Furthermore, the percentage of type I in the YOCr
group was similar to young controls. In young rats, the
overloaded plantaris had a significantly higher percentage
of type I fibers than overloaded plantaris from rats that
also received creatine. However, similar to the control group,
older animals in the AOCr group had a significantly higher
percentage of type I, and a significantly lower percentage of
type IIA fibers than young animals (Table 4). By contrast,
overload alone did not result in significant changes to fiber
type composition in aging animals.
A combination of creatine and surgical overload pro-
duced significant hypertrophy in most muscle fibers. In
young animals, the OCr treatment significantly increased
fiber CSA in type IIA and IIB/D fibers, relative to young
controls (IIA 28%, YOCr = 2401.51 ± 199.17µm2 versus
YC = 1724.26 ± 380.61µm2; and IIB/D 20%, YOCr =
4352.28 ± 519.12µm2 versus YC = 3642.04 ± 648.06µm2;
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resp.). In older animals, only type I and IIA fibers of the OCr
group were significantly larger than those fibers in the aging
control animals (I 23%, AOCr = 1949.01±180.77µm2 versus
AC = 1491.10 ± 299.40µm2; IIA17%, AOCr = 2125.66 ±
205.74µm2 versus AC = 1768.15 ± 209.31µm2, resp.). Type
IIB/D fibers of older animals in the OCr group did not
change fiber sizes over controls (Figure 2).
The combined eﬀects of creatine and overload diﬀer-
entially aﬀected the myonuclear domains in the plantaris
muscle of young and aging rats. For type IIA and IIB/D
fibers, myonuclear domain was significantly larger in fibers
of the YOCr group than in fibers from YC (IIA 24%, YOCr =
1934.58 ± 185.16µm2 versus YC = 1463.63 ± 400.77µm2;
IIB/D 25%, YOCr = 2559.80 ± 510.02µm2 versus YC =
1930.17±405.09µm2). In older rats, the myonuclear domain
was not significantly aﬀected by combined creatine and
overload, regardless of the fiber type (P > 0.05). Myonuclear
domain was significantly diﬀerent between fiber types within
age groups of animals in the overload plus creatine supple-
mentation groups, except there was no diﬀerence between
type I and IIA in YOCr (P = 0.102).
The combination of creatine and overload also resulted
in significantly greater fiber CSA than creatine alone in fiber
types I and IIA, regardless of age. For the CSA of type IIB/D
fibers, there was a trend toward significance between YOCr
and YCr groups (P = 0.051). This trend was not apparent
in the aging animals. The CSA of type IIB/D fibers were
significantly larger in YOCr than in YO animals, and there
was a similar trend in the CSA of type I fibers (P = 0.057). In
aging animals, there were no significant diﬀerences between
the CSA of AOCr and AO for any fiber types.
Type IIA fibers in YOCr animals had significantly lower
HSP70 content than in YO. However, HSP70 content of IIA
fibers of YOCr did not diﬀer in type IIA fibers of YC or
YCr cohorts. Creatine plus overload did not aﬀect HSP70
expression in the aging group, regardless of fiber type.
4. Discussion
Research has shown that creatine supplementation, in com-
bination with resistance training, can be beneficial in increas-
ing lean body mass and strength (reviewed in [34]). Only a
few studies have looked at creatine supplementation alone
in skeletal muscle tissue. Fewer still have examined the fiber
type-specific eﬀects of creatine supplementation on CSA
of aging muscle fibers. This study reports that the plantaris
muscles of young and aging rats respond similarly to surgical
overload. This is true for fiber type composition, cross-
sectional area, and myonuclear domain size. Further, our
data suggest that creatine supplementation alone had no
significant eﬀect on fiber CSA or HSP70 content, regardless
of age or fiber type and the combination of overload and
creatine also had minimal additional eﬀect, relative to over-
load alone.
4.1. Creatine Supplementation. One specific aim of this
research was to assess the eﬃcacy of creatine supplementa-
tion in agingmuscle. Few studies have examined the eﬀects of
creatine supplementation in the absence of exercise. Creatine
supplementation without exercise did not enhance anabolic
signals [35] or significantly alter fiber CSA [24]. Our data
agree with these findings-creatine supplementation alone
had no significant eﬀect on fiber CSA in young or aging ani-
mals, regardless of the fiber type. In vitro, creatine has been
shown to increase myosin heavy chain expression at both
mRNA and protein levels [36], but our data did not agree
with these findings.
Creatine supplementation alone had no eﬀect on CSA
or myonuclear domain for any fiber type in the plantaris of
aging animals. The authors are not aware of any previous
research that investigated fiber-specific changes subsequent
to creatine supplementation in aging muscle, so we propose
the following possible explanations for our findings. Creatine
supplementation significantly increases the myoprotective
eﬀects of carnosine and anserine in young, but not older ani-
mals [37]. Additionally, although creatine supplementation
increased muscle phosphocreatine concentrations in both
young and older adults, this response was significantly great-
er in the young adults [10]. Nonsupplementation studies also
indicate that aging muscle is less capable of synthesizing or
storing creatine. Compared to young skeletal muscle, aging
muscle has fewer stores of PCr and Cr and a lower rate of
PCr resynthesis [38].
4.2. Overload Surgery. A second specific aim of the current
research was to examine the ability of aging animals to
respond to a hypertrophic stimulus. Current results indicate
that the slower fiber phenotypes of aging animals maintain
their ability to hypertrophy in response to synergist ablation.
These data also indicate that the overload-induced fast-to-
slow fiber transition remains intact in older animals. These
findings are in agreement with much of the literature re-
lated to compensatory hypertrophy of young muscle [23,
39]. Relatively few studies have investigated compensatory
hypertrophy in older animals. The young and aging animals
in this study responded similarly to the overload surgery,
demonstrating that older muscle maintains the ability to hy-
pertrophy. These findings are in contrast to a few studies that
found a blunted response to overload in elderly animals [40–
42]. These diﬀerences may be explained by the age diﬀerence
in the “aging” group versus their elderly animals. Although
the muscle fibers of the 24 month older rats did not exhibit
age-associated atrophy, they did present other characteristics
associated with aging, such as a slower fiber phenotype. In
addition, the plantaris of the older groups had significantly
higher muscle mass compared to the young groups. The in-
creased muscle mass in the absence of fiber hypertrophy
may reflect a reduction in muscle quality. Infiltrations of fat
and noncontractile material are often noted in aging muscle
[43, 44].
4.3. Overload and Creatine Supplementation. A third specific
aim of this research was to examine the response of aging
muscle to a combination of creatine and overload. Compared
to the control group, the OCr treatment resulted in signif-
icant hypertrophy and significant increase in myonuclear
domain for IIA and IIB/D fibers in the young plantaris
muscle. In aging plantaris muscle, the combination of
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creatine and overload resulted in significant hypertrophy of
types I and IIA fibers, but myonuclear domain sizes were not
significantly diﬀerent between control animals and animals
in the OCr group for any fiber types. Compared to creatine
alone, OCr groups had significantly larger CSA of type IIA
fibers, regardless of age.
The additional benefit of creatine in the OCr group over
the O group was minimal. It is not immediately clear why the
combination of creatine and overload did not result in sig-
nificantly greater hypertrophy than overload alone. A com-
bination of creatine supplementation and resistance training
has previously been shown to result in larger fiber CSA
[45–47]. However, the present findings are in agreement
with R. E. Young, and J. C. Young [48], who demonstrat-
ed that creatine supplementation provided no additional
hypertrophy beyond synergist ablation alone in soleus and
extensor digitorum longus muscles. It is possible that the
overload model is not appropriate for examining the eﬀects
of creatine on resistance exercise. The proposed benefit of
creatine supplementation is to increase PCr stores, thereby
increasing the capacity to regenerate ATP stores during short
bursts of exercise [49]. In this scenario, the main benefit of
creatine supplementation is to sustain high-intensity work
for a longer duration [50]. In turn, the enhanced capacity
to anaerobically train the muscle leads to increases in muscle
mass and strength [7]. In the synergist ablation model, the
overload imposed upon the muscle is permanent, and there-
fore cannot be considered anaerobic exercise.
Creatine supplementation combined with overload sur-
gery also seems to influence the shift in muscle phenotype to
a slower phenotype. Interestingly, although both overloaded
muscle and aging muscle demonstrated an increase in slow
fibers, creatine supplemented animals of the aging group did
not show that fast-to-slow shift in fiber types in either ACr or
AOCr groups. This appears to show that the fiber type shift
in aging animals can potentially be altered or reduced.
There is a diﬀerent response between young and older
animals with regards to fiber type shift in response to over-
load. The young animals have an increase in the percentage of
both type I and type IIA fibers after overload, which is similar
to previous reports [23, 39]. However, in the aging overload,
and the young and aging OCr groups, there is a shift from
IIB/D to IIA, without a shift from IIA to I. Although the
young overload group had the greatest fast-to-slow shift in
fiber phenotype, this was not significantly diﬀerent from the
percent type I fibers in the aging animals with overload alone.
The aging animals had already undergone an age-related fast-
to-slow fiber shift, and the overload did not produce an
additional phenotype shift. Creatine appears to blunt the
overload-induced fast-to-slow fiber transition in the YOCr
group. However, since creatine alone does not cause any
significant shift in fiber type, we can only speculate that
it must be an interaction between overload and creatine
that negated the fast-to-slow shift seen in the YO group.
In addition, the young OCr group had the greatest percent
increases in CSA indicating the greatest response to the
interventions.
4.4. Myonuclear Domain. A further specific aim of this
project was to examine the age-specific eﬀects of creatine and
compensatory hypertrophy onmyonuclear domain size. Cre-
atine supplementation alone resulted in a significant increase
in myonuclear domain of types IIA and IIB/D fibers in young
animals whereas it had no eﬀect on myonuclear domain size
in aging animals. An increase in myonuclear domain implies
that fiber size increased at a disproportionately higher rate
than myonuclear addition. The results of this study indicate
that creatine alone resulted in trends toward hypertrophy
in young, but not aging, muscle fibers. Therefore, it is not
surprising that the creatine-induced increase of myonuclear
domain occurred only in the young animals. It is not clear
why the myonuclear domain size of type I fibers did not
significantly increase with creatine supplementation; how-
ever, fast-twitch fibers have relatively larger myonuclear do-
main sizes than slow-twitch fibers [51].
The concept of myonuclear domain implies that there is
an optimal amount of genetic material to govern the struc-
tural proteins in that domain. It has been reported that
if a fiber hypertrophies beyond 26%, myonuclei are added
to maintain a constant myonuclear domain [52]. In young
animals, type IIA fibers from the YCr, YO, and YOCr
treatment groups were all hypertrophied more than 26%. Of
these, the myonuclear domain size of the IIA fibers was also
increased in all three treatments. It is possible that the fibers
were in the process of increasing in size, and the myonuclei
had not yet had a chance to proliferate.
4.5. Heat Shock Protein 70. It appears that HSP70 could assist
in prevention of age-associated sarcopenia. Indeed, transgen-
ic overexpression of HSP70 in aging rats was able to rescue
damage-associated force deficits and speed recovery of the
muscles [53]. Furthermore, both induced HSP70 and HSP70
overexpression attenuated unloading-induced muscle atro-
phy [28]. This atrophy-attenuating quality of HSP70 is due,
at least in part, to the repression of the FOXO3a-induced
transcription of atrogin-1 [27].
Our data demonstrate a significant decrease in HSP70
content in type I and IIA fibers of aging rats, relative to young
rats. These findings partially agree with Naito and colleagues
[54], who found an insignificant decrease in HSP70 content
in the plantaris muscle of aging rats, relative to young
rats. In that study, HSP70 content was measured in muscle
homogenates, not individual fiber types. Given the high
percentage of type IID/B fibers in the plantaris and the
low HSP70 content in type IID/B fibers, it is reasonable to
conclude that homogenizing the muscle, as done in [54],
diluted any age-related diﬀerences that may have occurred
in HSP70 content. Conversely, Chung and Ng [55] demon-
strated a significant increase in HSP70 content in aging rats.
It is not possible to directly compare the two studies due
to diﬀerences in muscle (plantaris versus gastrocnemius),
technique (histochemistry versus Western blot), and ages
used (5m–24m versus 16m–29m).
Our data indicate that creatine supplementation alone
has no eﬀect on HSP70 content. Further, our data demon-
strate a creatine-induced attenuation to the overload-associ-
ated increase in HSP70 content, as evidenced by the lack
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of significance between C and OCr groups. To our knowl-
edge, these data are the first to examine the eﬀects of cre-
atine supplementation on HSP70 content. However, a link
has been established between energy availability and HSP70
expression. Exercise resulted in increased HSP70 expression
of glycogen-depleted skeletal muscle but not in glycogen-
containing control muscle [56]. It has also been demon-
strated that ADP acts as a cofactor in HSP70-peptide binding
interactions, and binding of HSP70 is directly correlated to
the ADP/ATP ratio [57]. A function of creatine supplemen-
tation is restoring ATP [49]. Therefore, the attenuation of
HSP70 content in OCr groups, relative to overload alone,
may be explained by the ability of creatine to maintain ATP
levels.
In the current study, the aging muscle shows an inability
to respond to creatine and (in comparison with the young
animals) a blunted response to overload. If creatine acts
directly on satellite cells, as has been shown in cell culture
[58], then the age-associated loss of responsiveness to cre-
atine may be a result of dysfunctional satellite cells. In young
individuals, creatine increased the quantity of both satel-
lite cells and myonuclei in young males, contributing to
enhanced growth [59].
Many age-related studies that have used a rat model have
documented an increase in body mass throughout the an-
imal’s lifespan. Fisher 344 rats were selected for this study,
because the body mass of this strain plateaus. 24 months
of age was selected for the aging group, because the NIH
survival curves indicate a 50% survival for Fisher 344 rats
at this age. Furthermore, 24-month-old Fisher 344 rats are
analogous to 80-year-old humans [60]. Age-associated chan-
ges in fiber type and CSA often accompany animals in this
age range [42, 61]. While the skeletal muscle of the aging
animals in this study did not exhibit some of the character-
istics commonly associated with sarcopenia, the aim of this
study was to determine whether the C/N characteristics and
responsiveness to overload and creatine change during the
aging process. The data demonstrate that these age-associ-
ated changes did occur, despite the absence of age-associated
declines of fast fiber types and fiber CSA.
4.6. Limitations. Interpretation of the present data is compli-
cated by a few limitations of the study. First, creatine uptake
by the muscle was not measured. Therefore, it is not clear
whether age-specific results were due to the inability of aging
muscle to take in creatine or to respond to the creatine.
Previous research has shown that creatine transporters are
not influenced by aging or activity [62]. Secondly, the
compensatory hypertrophymodel is an involuntarymodel of
extreme overload. Though it is a valid, common technique
for inducing hypertrophy in murine models, humans are
incapable of voluntarily exercising at this level of inten-
sity. Furthermore, creatine is believed to confer its eﬀect
on muscle by replenishing anaerobic energy stores, thereby
allowing users to perform an additional repetition of re
sistance exercise. As such, creatine supplementation may
result in greater gains if the training intensity can be
increased throughout the training period. For example,
significant increases in fat-free mass and strength were seen
when creatine supplementation was coupled with resistance
training, modified to maintain maximal eﬀort [18]. It should
be noted that in the Brose et al. [18] study, fiber CSA was
similar between creatine- and placebo-supplemented groups.
Nevertheless, compensatory hypertrophy is a form of perma-
nent overload that cannot be modified incrementally and is
a limitation of the study. Lastly, this study did not quantify
protein synthesis or degradation. The ratio of protein syn-
thesis and degradation is known to change with aging [1].
Creatine supplementation has been linked to protein syn-
thesis [47]; therefore, measuring these indices may have
enhanced the study.
4.7. Summary. Given the prevalence of age-associated sar-
copenia, the search for a preventative supplement is of vital
importance. The data presented here indicate that creatine
supplementation alone does not aﬀect fiber hypertrophy in
aging muscle. Furthermore, this study found that a combi-
nation of creatine and overload was no more eﬀective than
overload alone on hypertrophy. In fact, the creatine sup-
plementation appeared to result in a small, but significant,
attenuation of overload-induced HSP70 expression.
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